Chan Mitchell
- SEC CIK
- 0001789335
In the past year, 1 open-market sale filing worth $72.5K and no purchases.
Current role at each company
- RGNX REGENXBIO Inc.Chief Financial Officeras of Sep 3, 2026
- AVTX Avalo Therapeutics, Inc.Directoras of May 7, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $72.5K
- 1 filing
- Net
- −$72.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Chan Mitchell as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AVTX Avalo Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 (view filing) | May 6 | 1 day | Chan MitchellDirector | SSale | −3.17K | $22.88 | −$72.5K | −50.0%3.17K after | 10b5-1 |